Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease ...

Ainos (AIMD) announces the granting of a pivotal invention patent in Japan for its oral interferon formulation, VELDONA, to treat and prevent coronavirus infections. The newly granted patent ...

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a pioneer of digitizing scent, proudly announces its revolutionary AI Nose for robotics application and invites robotics companies worldwide to join Ainos ...

About Ainos, Inc. Headquartered in San Diego, California, Ainos, Inc. develops disruptive medical and healthcare solutions based on its proprietary AI Nose and VELDONA® technologies.

SAN DIEGO, CA / ACCESS Newswire / January 27, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") proudly announces the granting of a pivotal invention patent in Japan ...

Robotics Integration: WTR noted that Ainos's strategic focus on positioning its AI Nose technology as a critical sensory enhancement for robotics and humanoid applications. The Company is actively ...